Unique ID issued by UMIN | UMIN000012960 |
---|---|
Receipt number | R000015154 |
Scientific Title | Comparison of combined assay for serum anti-Helicobacter pylori immunoglobulin G titer and serum pepsinogen levels - "ABC method" and histopathological diagnosis for the risk assessment of gastric cancer. |
Date of disclosure of the study information | 2014/01/31 |
Last modified on | 2017/07/30 20:57:42 |
Comparison of combined assay for serum anti-Helicobacter pylori immunoglobulin G titer and serum pepsinogen levels - "ABC method" and histopathological diagnosis for the risk assessment of gastric cancer.
Comparison of combined assay for serum anti-Helicobacter pylori immunoglobulin G titer and serum pepsinogen levels - "ABC method" and histopathological diagnosis for the risk assessment of gastric cancer.
Comparison of combined assay for serum anti-Helicobacter pylori immunoglobulin G titer and serum pepsinogen levels - "ABC method" and histopathological diagnosis for the risk assessment of gastric cancer.
Comparison of combined assay for serum anti-Helicobacter pylori immunoglobulin G titer and serum pepsinogen levels - "ABC method" and histopathological diagnosis for the risk assessment of gastric cancer.
Japan |
Patients with suspicious gastritis and/or infection of Helicobacter pylori.
Gastroenterology |
Others
NO
The aim of this study is to investigate the relationship between combined assay for serum anti-Helicobacter pylori immunoglobulin G titer and serum pepsinogen levels and histopathological diagnosis for the risk assessment of gastric cancer.
Efficacy
Agreement of the results of the two (combined assay for serum anti-Helicobacter pylori immunoglobulin G titer and serum pepsinogen levels and histopathological diagnosis) diagnostic tests.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Diagnosis
Maneuver | Other |
Blood sampling and endoscopic biopsy.
20 | years-old | <= |
Not applicable |
Male and Female
Patients with suspicious gastritis and/or infection of Helicobacter pylori.
The exclusion criteria included any contraindication for esophagogastroduodenoscopy.
100
1st name | |
Middle name | |
Last name | Kenji Tominaga. |
Toho University Ohashi Medical Center.
Division of Gastroenterology and Hepatology, Department of Internal Medicine.
2-17-6 Ohashi, Meguro-ku, Tokyo 153-8515, Japan.
03-3468-1251
kenjitominaga@hotmail.com
1st name | |
Middle name | |
Last name | Kenji Tominaga. |
Toho University Ohashi Medical Center.
Division of Gastroenterology and Hepatology, Department of Internal Medicine.
2-17-6 Ohashi, Meguro-ku, Tokyo 153-8515, Japan.
03-3468-1251
kenjitominaga@hotmail.com
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Ohashi Medical Center.
None.
Self funding
NO
東邦大学医療センター大橋病院(東京都)
2014 | Year | 01 | Month | 31 | Day |
Unpublished
Completed
2014 | Year | 01 | Month | 20 | Day |
2014 | Year | 02 | Month | 01 | Day |
2014 | Year | 01 | Month | 26 | Day |
2017 | Year | 07 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015154
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |